Overbought Stocks — Overview View · Pharmaceutical Preparations
31 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Overview columns. Filtered to Pharmaceutical Preparations. Updated
Filters2
1–31 of 31
| ARTL | ARTELO BIOSCIENCES, INC. | Healthcare | Pharmaceutical Preparations | $30M | -2.39 | 6.59 | +0.15% | Buy | 811 |
| VOGX | Vogenx, Inc. | Healthcare | Pharmaceutical Preparations | — | — | 32.42 | +0.00% | Strong Sell | 4K |
| CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | Pharmaceutical Preparations | $9.0B | -17.96 | 84.96 | +0.13% | Buy | 161K |
| LGVN | Longeveron Inc. | Healthcare | Pharmaceutical Preparations | $186M | -7.91 | 6.61 | -3.22% | Buy | 973 |
| XBIO | Xenetic Biosciences, Inc. | Healthcare | Pharmaceutical Preparations | $11M | -4.39 | 4.64 | +7.66% | Buy | 1K |
| CMMB | Chemomab Therapeutics Ltd. | Healthcare | Pharmaceutical Preparations | — | — | 2.82 | +3.30% | Buy | 3K |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | Healthcare | Pharmaceutical Preparations | $238M | -271.56 | 2.21 | +31.55% | Buy | 542K |
| AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | Pharmaceutical Preparations | $1.0B | 12.92 | 23.85 | +0.44% | Buy | 24K |
| RNXT | RenovoRx, Inc. | Healthcare | Pharmaceutical Preparations | $106M | -8.60 | 2.34 | -9.30% | Strong Buy | 77K |
| BMEA | Biomea Fusion, Inc. | Healthcare | Pharmaceutical Preparations | $138M | -4.25 | 1.91 | -1.04% | Buy | 35K |
| HOWL | Werewolf Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | $46M | -1.33 | 0.94 | -4.65% | Buy | 12K |
| HCM | HUTCHMED (China) Ltd | Healthcare | Pharmaceutical Preparations | — | — | 14.09 | +17.22% | Buy | 13K |
| QNRX | Quoin Pharmaceuticals, Ltd. | Healthcare | Pharmaceutical Preparations | — | — | 7.40 | +13.32% | Neutral | 8K |
| VBIO | Valion Bio, Inc. | Healthcare | Pharmaceutical Preparations | $62M | -3.31 | 2.80 | -10.26% | Buy | 174 |
| JANX | Janux Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | $1.2B | -11.82 | 19.83 | +0.71% | Buy | 72K |
| CELU | Celularity Inc | Healthcare | Pharmaceutical Preparations | $54M | -0.58 | 1.85 | +0.82% | Buy | 3K |
| FTH | Faeth Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | — | — | 40.27 | +2.82% | Buy | 21K |
| OGN | Organon & Co. | Healthcare | Pharmaceutical Preparations | $3.6B | 17.31 | 13.78 | +0.00% | Buy | 148K |
| GLMD | Galmed Pharmaceuticals Ltd. | Healthcare | Pharmaceutical Preparations | — | — | 4.01 | -1.72% | Strong Buy | 229 |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | $2.4B | -17.76 | 22.99 | -0.95% | Buy | 180K |
| CYCN | Cyclerion Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | $24M | -3.59 | 5.14 | +13.47% | Buy | 5K |
| OMER | Omeros Corp | Healthcare | Pharmaceutical Preparations | $1.4B | 11.09 | 19.12 | +1.27% | Buy | 49K |
| ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | Pharmaceutical Preparations | $442M | -4.74 | 15.56 | -7.07% | Strong Buy | 41K |
| LEXX | Lexaria Bioscience Corp. | Healthcare | Pharmaceutical Preparations | $305M | -39.46 | 12.31 | -7.44% | Buy | 764 |
| APLM | Apollomics Inc. | Healthcare | Pharmaceutical Preparations | — | — | 26.73 | +0.53% | Buy | 2 |
| NGEN | NERVGEN PHARMA CORP. | Healthcare | Pharmaceutical Preparations | — | — | 2.31 | -0.86% | Buy | 27K |
| VSTM | Verastem, Inc. | Healthcare | Pharmaceutical Preparations | $723M | -3.57 | 7.98 | -0.25% | Buy | 151K |
| AQST | Aquestive Therapeutics, Inc. | Healthcare | Pharmaceutical Preparations | $671M | -8.58 | 5.35 | -0.47% | Buy | 97K |
| MNOV | MEDICINOVA INC | Healthcare | Pharmaceutical Preparations | $79M | -7.39 | 1.61 | +11.76% | Buy | 3K |
| KYNB | KYNTRA BIO, INC. | Healthcare | Pharmaceutical Preparations | $34M | — | 8.50 | -0.53% | Buy | 243 |
| EOLS | Evolus, Inc. | Healthcare | Pharmaceutical Preparations | $598M | -17.43 | 9.06 | +0.06% | Buy | 42K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.